p38 plays a central role in inflammation and regulates the production of inflammatory mediators such as TNFα, IL1β, and COX2 (43), thus it is possible that increased p38 activation in propranolol-treated IHs may mediate IH regression through immune-mediated responses. Here, IL1B is linked to isolated hemihyperplasia.